IOVANCE BIOTHERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -55.1% | -55.1% | -44.0% |
| FY2022 | -79.2% | -79.2% | -59.6% |
| FY2023 | -76.0% | -76.0% | -56.9% |
| FY2024 | -52.4% | -52.4% | -40.9% |
| FY2025 | -56.0% | -56.0% | -42.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -55.1% | -55.1% | -44.0% |
| FY2022 | -79.2% | -79.2% | -59.6% |
| FY2023 | -76.0% | -76.0% | -56.9% |
| FY2024 | -52.4% | -52.4% | -40.9% |
| FY2025 | -56.0% | -56.0% | -42.8% |